Abstract: The use of a composition which comprises lignosulfonate for the prevention and treatment of pathogenic and medical disorders in humans and animals. In some embodiments the composition is substantially free of elemental sulphur. In some embodiments the lignosulfonate is radically polymerized. In some embodiments the composition is formulated as an animal feed additive or supplement. The disclosure also encompasses a method of preventing or treating a pathogenic or medical disorder in a human or animal subject by administering the composition to the subject in an effective dose to attenuate the pathogenic effect of a pathogen or other biological agent, thereby enabling the subject to mount an effective immune response to the pathogen or other biological agent.

Abstract: The use of compositions comprising lignosulfonate for attenuation of SARS-CoV-2 virus replication. The compositions can be used in methods for preventing and treating COVID-19 and other medical disorders caused by or associated with SARS-CoV-2 virus replication in humans and animals. In some embodiments the compositions are substantially free of elemental sulphur. In some embodiments the lignosulfonate is radically polymerized. In some embodiments the compositions are formulated as an animal feed additive or supplement. The disclosure encompasses compositions comprising lignosulfonate and methods of preventing or treating COVID-19 by administering compositions comprising lignosulfonate to human or animal subjects in an effective dose to attenuate the pathogenic effect of the SARS-CoV-2 virus.

Abstract: The use of a composition which comprises lignosulfonate and is substantially free of elemental sulphur for the prevention and treatment of pathogenic and medical disorders in humans and animals. In some embodiments the lignosulfonate is radically polymerized. In some embodiments the composition is formulated as an animal feed additive or supplement. The disclosure also encompasses a method of preventing or treating a pathogenic or medical disorder in a human or animal subject by administering the composition to the subject in an effective dose to attenuate the pathogenic effect of a pathogen or other biological agent, thereby enabling the subject to mount an effective immune response to the pathogen or other biological agent.